Benign neoplasm: Central nervous system, other parts/unspecified

CD2_BENIGN_CNS_NOS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D33.7&
  • Hospital discharge: ICD-9 — 2259
  • Hospital discharge: ICD-8 — 2259
  • Cause of death: ICD-10 — D33.7&
  • Cause of death: ICD-9 — 2259
  • Cause of death: ICD-8 — 2259

2 out of 7 registries used, show all original rules.

138

4. Check minimum number of events

None

138

5. Include endpoints

None

138

6. Filter based on genotype QC (FinnGen only)

133

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D33
Name in latin
Neoplasma benignum alterius partis specificatae systematis nervosi centralis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1132 596 527
Only index persons 873 465 408
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.01
Only index persons 0.02 0.02 0.02
Median age at first event (years)
Whole population 48.75 50.58 46.64
Only index persons 46.11 47.21 44.85

-FinnGen-

Key figures

All Female Male
Number of individuals 133 70 63
Unadjusted period prevalence (%) 0.03 0.02 0.03
Median age at first event (years) 50.01 51.47 48.38

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
138
Matched controls
1380
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
+∞
139.1
109
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.7
20.0
38
74
2259X
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Nervous system, part unspecified
+∞
18.1
17
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
33.0
15.7
20
7
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
+∞
13.8
13
*
XCK00
NOMESCO Finland
Perimetry
6.2
12.3
23
43
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
12.1
11.2
20
19
22599
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Unspecified site
+∞
10.5
10
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
28.4
10.0
13
5
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
32.6
9.6
12
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.3
8.9
19
40
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.0
8.8
28
82
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
95.7
8.5
9
*
D33.30
ICD-10 Finland
Acoustic neuroma
95.7
8.5
9
*
9560/0-C72.9
ICD-O-3
Schwannoma, NOS, of nervous system, NOS
+∞
8.4
8
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
7.4
7
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
+∞
7.4
7
*
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
23.9
6.8
9
*
D33.07
ICD-10 Finland
Colloid coast in cerebral ventricle
73.1
6.5
7
*
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
+∞
6.3
6
*
2152
FHL
Extraction, big brain
+∞
6.3
6
*

TimeCodeWAS

↥

TimeCodeWAS is a tool for exploring time-dependent associations between an endpoint and health codes (diagnoses, lab tests, procedures, etc.).

The TimeCodeWAS analysis is done in three steps:

  1. Build a matched case-control set for this endpoint. Each case is matched to 5–10 controls on sex and year of birth, and controls must be at risk at the same age as the case's age of onset. TimeCodeWAS allows for controls to be reused.
  2. Count cases and controls. For each health code, and for each time window: tally the counts into a 2×2 table. To be eligible in a time window, a case or control must have data coverage for at least 50% of that time window.
  3. Perform association tests. If all cells of the 2×2 table have N≥10, then a χ² test is performed, otherwise a Fisher's exact test is done. The corresponding p-value and confidence interval are reported below, along with the standard odds ratio when a χ² test is done, or Fisher's MLE odds ratio otherwise.

TimeCodeWAS currently uses the same default set of time windows for all the endpoints. Please reach out to us if you have suggestions for better time windows for some endpoints. The default time windows are: TimeCodeWAS time windows

Sort & Filter
Sort
Odds Ratio
among windows:
Filter
Code & OMOP
Cases and controls with code
in
Odds Ratio
in
OMOP Concept
Code (OMOP Vocabulary) [OMOP Concept ID]
OMOP Concept Class / OMOP Domain
Odds Ratio
TimeCodeWAS O.R. time legend
Cases and controls with code
TimeCodeWAS Cases and Controls percentages time legend
Outpatient Visit
OP (Visit) [9202]
Visit / Visit
6.5e-01 9.6e-01 9.9e-01 5.5e+00 1.1e+00 1.5e+00 1.3e+00
68.55%/53.20% 62.10%/38.46% 17.74%/7.45% 49.19%/0.40% 20.16%/8.03% 74.38%/38.31% 85.45%/62.51%
Neurosurgery
14 (Medicare Specialty) [38004459]
Physician Specialty / Provider
3.2e+00 3.4e+00 — 1.0e+50 1.0e+50 4.7e+00 3.1e+00
25.81%/1.46% 20.97%/0.89% —/— 53.23%/0.00% 9.68%/0.00% 39.67%/0.58% 34.55%/2.31%
Neurology
13 (Medicare Specialty) [38004458]
Physician Specialty / Provider
1.3e+00 3.0e+00 2.1e+00 1.0e+50 3.3e+00 2.5e+00 1.8e+00
20.97%/6.96% 29.03%/1.94% 4.03%/0.49% 18.55%/0.00% 13.71%/0.57% 28.10%/3.07% 38.18%/8.96%
Extensive MRI examination of brain with high intensity magnet
AA1CG (NCSPfi) [2001300116]
NCSPfi Level 3 / Procedure
1.9e+00 — — — — — 3.2e+00
6.45%/1.05% —/— —/— —/— —/— —/— 10.00%/0.46%
34531-4 (LOINC) [3044640]
Lab Test / Measurement
4.2e-01 1.9e+00 — — — 3.0e+00 9.6e-01
4.84%/3.24% 6.45%/1.05% —/— —/— —/— 7.44%/0.41% 9.09%/3.69%
Case Management Agency
251B00000X (NUCC) [38004193]
Visit / Visit
1.5e-01 1.9e-01 6.8e-01 2.9e+00 7.5e-01 1.7e-01 4.0e-01
48.39%/44.53% 41.94%/37.41% 23.39%/13.44% 18.55%/1.21% 26.61%/14.68% 42.98%/38.81% 66.36%/57.06%
Inpatient Hospital
21 (CMS Place of Service) [8717]
Visit / Visit
6.4e-01 1.1e+00 — — 2.8e+00 1.3e+00 7.0e-01
37.10%/23.64% 20.16%/7.61% —/— —/— 12.10%/0.81% 23.14%/7.79% 38.18%/23.55%
Supplier / Service Provider
OMOP5117446 (Visit) [33004]
Visit / Visit
-1.2e+00 -7.7e-01 — — — — 2.8e+00
10.48%/27.45% 4.03%/8.34% —/— —/— —/— —/— 10.91%/0.74%
Outpatient Hospital
22 (CMS Place of Service) [8756]
Visit / Visit
4.7e-01 1.1e+00 — — 2.7e+00 1.6e+00 1.1e+00
27.42%/19.03% 16.13%/5.99% —/— —/— 8.87%/0.65% 23.14%/5.64% 37.27%/16.81%

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
45
234
2.37
4.99
2.6
2.6
2.43
2.45
mmol/l
0.69
38
205
30
145
2.37
3.84
6.4
14.0
0.82
1.07
mmol/l
0.15
25
123
64
418
1.99
3.80
2.5
3.5
2.37
2.36
mmol/l
0.41
56
372
60
386
1.98
3.69
2.8
2.6
—
—
—
0
0
30
148
2.31
3.66
6.4
13.9
7.41
7.42
ph
0.34
14
88
24
111
2.41
3.37
1.9
2.0
0.00
0.00
estimate
—
7
24
19
81
2.56
3.15
1.2
1.1
25.87
124.92
u/ml
—
6
30
8
16
5.24
3.10
2.3
1.6
—
—
nmol/l
—
0
0
14
52
2.88
2.99
5.3
4.6
36.88
36.98
°c
0.47
14
52
75
549
1.80
2.90
12.1
14.2
1.18
1.24
inr
0.41
61
459
72
521
1.80
2.89
3.3
3.1
—
—
estimate
—
0
0
8
20
4.18
2.61
2.1
1.5
0.16
0.16
nmol/l
—
8
12
31
183
1.90
2.34
7.0
9.1
104.48
103.93
mmol/l
0.22
31
183
53
374
1.68
2.18
4.9
4.0
0.00
0.03
estimate
0.74
17
112
61
447
1.65
2.17
2.2
2.1
—
—
—
0
0
49
340
1.68
2.14
5.2
4.6
—
—
—
0
0
105
894
1.73
2.00
5.9
4.3
14.86
14.76
pmol/l
0.15
99
811
50
356
1.63
1.95
3.5
3.2
—
—
—
0
0
14
67
2.21
1.83
1.2
1.3
—
—
—
0
0
7
23
3.15
1.82
1.0
2.9
—
—
—
0
0
40
275
1.64
1.78
2.0
2.0
0.84
1.56
mg/l
1.38
33
228
13
62
2.21
1.72
1.2
2.1
0.00
0.00
estimate
—
6
19
81
661
1.55
1.70
4.7
4.0
0.00
0.00
estimate
-0.00
17
122
75
604
1.53
1.66
8.9
9.8
1.21
1.21
mmol/l
0.06
66
525
86
715
1.54
1.63
7.2
10.6
4.55
4.14
e9/l
0.78
75
630
20
115
1.86
1.63
8.5
12.6
—
—
—
0
0
81
665
1.53
1.63
4.7
4.0
0.00
12.79
estimate
0.50
17
127
10
44
2.37
1.59
1.4
1.3
—
—
—
0
0
15
79
2.01
1.56
3.6
10.3
—
—
—
0
0
8
33
2.51
1.56
10.1
14.5
—
—
—
0
0
81
670
1.51
1.54
4.7
4.1
0.00
0.00
estimate
-0.00
17
118
5
15
3.42
1.53
1.4
1.1
—
—
—
0
0
19
110
1.84
1.52
8.5
11.0
1.31
1.29
mmol/l
0.05
19
110
5
16
3.20
1.45
1.2
1.3
—
—
—
0
0
21
130
1.73
1.36
2.8
5.2
7.41
7.39
ph
—
10
84
60
478
1.45
1.32
4.4
3.8
40.98
31.01
ng/l
0.18
47
351
125
1158
1.84
1.28
20.3
16.6
21.92
23.73
mg/l
0.28
107
944
29
202
1.55
1.21
1.8
1.7
1377.33
1248.06
nmol/l
0.33
24
148
5
20
2.55
1.16
2.2
1.5
29.28
37.05
ng/l
—
5
20
5
20
2.55
1.16
2.8
3.2
125.14
187.50
u/ml
—
5
20
32
230
1.51
1.16
1.4
1.3
15.78
31.16
iu/ml
—
10
75
40
302
1.46
1.14
4.6
4.1
1.02
1.02
kg/l
0.32
28
197
22
146
1.60
1.12
1.3
1.3
—
—
—
0
0
91
799
1.41
1.09
5.1
4.6
—
—
—
0
0
10
53
1.96
1.04
2.7
2.0
—
—
—
0
0
7
35
2.05
1.01
1.4
1.8
—
—
—
0
0
7
35
2.05
1.01
1.1
1.2
—
—
—
0
0
12
191
0.59
0.93
1.9
1.6
—
—
—
0
0
60
502
1.35
0.92
5.0
3.9
0.00
0.03
estimate
0.50
11
101
77
669
1.34
0.92
6.3
6.8
0.19
0.19
e9/l
0.15
67
590
64
541
1.34
0.92
3.8
3.7
6.31
6.30
ph
0.02
39
304
125
1178
1.65
0.91
25.4
19.8
139.72
139.59
mmol/l
0.23
125
1156
125
1178
1.65
0.91
25.1
19.9
3.93
3.98
mmol/l
1.50
125
1153
114
1059
1.44
0.84
7.0
5.4
1.76
1.92
mu/l
0.81
108
960
56
469
1.33
0.84
4.1
4.5
18.78
70.03
e6/l
1.63
49
331
5
99
0.49
0.81
1.0
1.6
—
—
—
0
0
0
24
0.00
0.80
0.0
1.0
—
—
—
0
0
41
498
0.75
0.79
1.8
2.0
1.50
1.37
mmol/l
0.43
36
418
0
26
0.00
0.79
0.0
2.6
—
16.11
—
0
26
16
108
1.54
0.77
1.4
1.3
—
—
—
0
0
74
650
1.30
0.77
6.6
6.4
1.77
1.93
e9/l
0.49
66
582
12
76
1.63
0.74
2.1
5.5
23.89
24.56
mmol/l
0.20
12
76
10
60
1.72
0.74
4.6
4.1
24.78
24.43
mmol/l
—
10
60
36
289
1.33
0.71
2.5
2.1
2.87
2.80
mg/l
0.08
31
260
72
637
1.27
0.68
6.6
6.4
0.57
0.58
e9/l
0.11
65
557
17
121
1.46
0.66
2.1
2.8
0.22
0.22
g/l
0.02
17
111
22
166
1.39
0.63
1.2
1.3
—
—
—
0
0
46
388
1.28
0.63
4.0
4.3
7.39
7.40
ph
0.31
32
281
11
162
0.65
0.63
2.4
1.6
—
—
—
0
0
8
50
1.64
0.62
1.0
1.1
—
—
—
0
0
72
642
1.25
0.62
6.6
6.4
0.04
0.04
e9/l
0.35
64
556
8
51
1.60
0.61
2.1
1.8
0.86
6.35
ug/l
—
8
45
8
51
1.60
0.61
2.4
5.1
—
—
—
0
0
0
20
0.00
0.61
0.0
2.1
—
—
—
0
0
13
89
1.51
0.60
9.4
11.2
25.92
25.03
mmol/l
0.52
13
89
59
516
1.25
0.60
2.6
2.2
91.64
94.47
pmol/l
0.23
36
270
26
205
1.33
0.58
1.4
1.3
1.30
7.97
u/ml
—
9
83
20
151
1.38
0.58
1.5
1.7
—
—
—
0
0
30
245
1.29
0.53
1.9
1.8
487.83
453.70
pmol/l
0.25
24
205
30
356
0.80
0.46
3.7
3.2
—
0.29
—
0
7
24
291
0.79
0.44
1.6
1.5
2.86
2.74
g/l
0.07
18
162
34
290
1.23
0.42
4.6
4.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
1.83
—
0
9
0
16
0.00
0.41
0.0
1.0
—
1.42
—
0
9
46
406
1.20
0.41
5.3
3.8
—
—
—
0
0
0
17
0.00
0.41
0.0
3.2
—
—
—
0
0
0
18
0.00
0.40
0.0
2.0
—
89.45
—
0
18
12
89
1.38
0.39
4.1
3.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
0.17
—
0
11
115
1105
1.24
0.38
4.9
4.4
1.23
1.26
mmol/l
0.28
105
1006
28
238
1.22
0.36
4.0
3.3
468.79
529.34
mosm/kgh2o
0.86
28
205
42
374
1.18
0.34
2.0
1.7
16.05
22.11
nmol/l
2.71
37
313
10
75
1.36
0.31
4.3
2.7
0.74
0.64
%
—
10
75
26
224
1.20
0.30
1.8
1.8
—
—
—
0
0
10
76
1.34
0.29
4.3
2.6
1.40
1.32
%
—
10
76
11
87
1.29
0.25
1.6
1.8
—
—
—
0
0
43
469
0.88
0.25
2.6
3.2
—
—
—
0
0
125
1223
1.23
0.24
27.6
21.2
76.27
78.46
umol/l
0.46
125
1211
5
38
1.33
0.23
1.2
1.4
—
—
—
0
0
5
39
1.29
0.23
1.2
1.4
—
—
—
0
0
5
39
1.29
0.23
5.0
4.0
1.80
4.67
ratio
—
5
18
5
39
1.29
0.23
1.2
1.4
—
—
—
0
0
5
40
1.26
0.22
1.2
1.4
—
—
—
0
0
5
41
1.23
0.22
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
19596.00
—
0
5
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
711.88
—
0
8
6
48
1.26
0.20
3.5
2.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
27
243
1.14
0.19
3.8
3.7
16.83
284.19
ng/l
1.44
18
182
12
100
1.22
0.19
2.3
2.0
6.21
6.16
ph
—
7
64
61
578
1.10
0.18
6.9
6.5
58.05
57.60
%
0.13
56
551
11
131
0.83
0.18
2.4
4.1
2.15
44.76
ug/l
0.71
11
107
7
62
1.14
0.17
2.7
2.5
25.57
20.19
s
—
7
57
5
66
0.75
0.17
1.6
1.2
—
—
—
0
0
8
69
1.17
0.17
1.3
1.2
—
—
—
0
0
119
1168
1.14
0.15
6.1
5.9
2.77
2.70
mmol/l
0.43
111
1081
61
582
1.09
0.15
7.0
6.5
2.82
2.74
%
0.12
56
545
61
582
1.09
0.15
7.1
6.7
9.45
8.89
%
0.84
56
547
15
132
1.15
0.14
1.3
1.3
—
—
—
0
0
112
1098
1.11
0.13
6.9
6.3
38.95
39.27
mmol/mol
0.15
107
1021
33
308
1.09
0.13
1.5
1.5
—
—
—
0
0
124
1222
1.15
0.13
14.5
12.3
24.78
25.74
u/l
0.32
124
1187
15
133
1.14
0.12
1.6
1.6
—
—
—
0
0
52
544
0.93
0.12
14.7
11.9
0.00
0.00
e9/l
0.71
43
436
60
579
1.06
0.10
7.2
6.6
0.74
0.65
%
0.50
55
539
5
45
1.12
0.10
5.6
4.6
14.64
25.67
mg/l
—
5
38
5
45
1.12
0.10
5.6
4.6
21.44
72.92
mg/l
—
5
38
116
1144
1.09
0.09
5.7
5.2
1.44
1.46
mmol/l
0.25
109
1051
38
397
0.94
0.08
3.1
4.0
3.63
9.67
mg/mmol
1.54
22
254
10
89
1.13
0.07
5.4
3.4
—
—
—
0
0
116
1147
1.07
0.06
5.6
5.2
4.68
4.61
mmol/l
0.33
109
1061
40
414
0.95
0.06
2.8
3.6
7.04
7.93
mmol/l
0.75
33
349
126
1250
1.09
0.05
31.5
24.9
90.88
91.08
fl
0.24
126
1239
126
1250
1.09
0.05
32.2
25.7
40.67
40.47
%
0.22
126
1236
126
1250
1.09
0.05
31.4
24.8
30.23
30.35
pg
0.36
126
1239
22
231
0.94
0.04
3.3
2.9
0.88
0.92
ug/l
0.05
16
134
41
398
1.04
0.04
7.5
7.1
—
—
—
0
0
126
1251
1.08
0.04
31.8
25.1
135.67
135.37
g/l
0.08
126
1237
30
309
0.96
0.02
1.3
1.3
0.73
1.83
u/ml
1.14
15
79
12
127
0.94
0.01
1.4
1.6
—
—
—
0
0
38
387
0.98
0.01
2.9
3.3
16.92
60.93
mg/l
2.68
26
259
41
403
1.02
0.01
7.0
6.5
—
—
—
0
0
36
354
1.02
0.00
4.9
3.5
0.00
0.00
estimate
-0.00
14
96
18
184
0.98
0.00
2.9
2.2
—
—
—
0
0
16
161
0.99
0.00
1.6
1.6
—
—
—
0
0
11
113
0.97
0.00
1.2
1.2
—
—
—
0
0
12
123
0.97
0.00
1.3
3.7
81.68
67.94
e9/l
—
6
90
119
1188
1.01
0.00
18.0
14.6
—
—
—
0
0
97
966
1.01
0.00
23.4
21.3
13.62
13.65
%
0.09
97
959
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
1.20
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
1766.67
—
0
9
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
73.71
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
9.1
—
16.46
—
0
9
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_CNS_NOS and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_CNS_NOS 1.387 [1.01, 1.9] 0.041
Birth year 1.001 [0.99, 1.01] 0.808

During the follow-up period (1.1.1998 — 31.12.2019), 52 out of 315 females with CD2_BENIGN_CNS_NOS died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_CNS_NOS 1.853 [1.28, 2.68] 0.001
Birth year 0.989 [0.98, 1.0] 0.022

During the follow-up period (1.1.1998 — 31.12.2019), 60 out of 283 males with CD2_BENIGN_CNS_NOS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_CNS_NOS.

N-year risk Females Males
1 0.154% 0.343%
5 0.934% 2.159%
10 2.392% 5.722%
15 4.796% 10.819%
20 8.598% 17.648%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_CNS_NOS – Benign neoplasm: Central nervous system, other parts/unspecified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data